The impact of rifampin drug interactions on tuberculosis preventive treatment completion and safety.
Saved in:
| Title: | The impact of rifampin drug interactions on tuberculosis preventive treatment completion and safety. |
|---|---|
| Authors: | Fregonese F; McGill International TB Centre, McGill University, Montreal, QC, Canada., White J; Calgary Tuberculosis Services, Alberta Health Services, Calgary, AB, Canada., Lim RK; Calgary Tuberculosis Services, Alberta Health Services, Calgary, AB, Canada;, Division of Respiratory Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Bedingfield N; Calgary Tuberculosis Services, Alberta Health Services, Calgary, AB, Canada;, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Cook VJ; Department of Medicine, University of British Columbia, Vancouver, BC, Canada;, Provincial TB Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada., Gafar F; McGill International TB Centre, McGill University, Montreal, QC, Canada;, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada;, Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia., Gibson D; McGill International TB Centre, McGill University, Montreal, QC, Canada., Menzies D; McGill International TB Centre, McGill University, Montreal, QC, Canada;, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Fisher D; Calgary Tuberculosis Services, Alberta Health Services, Calgary, AB, Canada;, Division of Respiratory Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. |
| Source: | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2026 Mar 27; Vol. 30 (4), pp. 167-173. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: International Union against Tuberculosis and Lung Disease Country of Publication: France NLM ID: 9706389 Publication Model: Print Cited Medium: Internet ISSN: 1815-7920 (Electronic) Linking ISSN: 10273719 NLM ISO Abbreviation: Int J Tuberc Lung Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41896715 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The impact of rifampin drug interactions on tuberculosis preventive treatment completion and safety. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fregonese+F%22">Fregonese F</searchLink>; McGill International TB Centre, McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22White+J%22">White J</searchLink>; Calgary Tuberculosis Services, Alberta Health Services, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Lim+RK%22">Lim RK</searchLink>; Calgary Tuberculosis Services, Alberta Health Services, Calgary, AB, Canada;, Division of Respiratory Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Bedingfield+N%22">Bedingfield N</searchLink>; Calgary Tuberculosis Services, Alberta Health Services, Calgary, AB, Canada;, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Cook+VJ%22">Cook VJ</searchLink>; Department of Medicine, University of British Columbia, Vancouver, BC, Canada;, Provincial TB Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Gafar+F%22">Gafar F</searchLink>; McGill International TB Centre, McGill University, Montreal, QC, Canada;, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada;, Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.<br /><searchLink fieldCode="AU" term="%22Gibson+D%22">Gibson D</searchLink>; McGill International TB Centre, McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Menzies+D%22">Menzies D</searchLink>; McGill International TB Centre, McGill University, Montreal, QC, Canada;, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Fisher+D%22">Fisher D</searchLink>; Calgary Tuberculosis Services, Alberta Health Services, Calgary, AB, Canada;, Division of Respiratory Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229706389%22">The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</searchLink> [Int J Tuberc Lung Dis] 2026 Mar 27; Vol. 30 (4), pp. 167-173. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Union+against+Tuberculosis+and+Lung+Disease%22">International Union against Tuberculosis and Lung Disease </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>9706389 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1815-7920 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210273719%22">10273719 </searchLink><i>NLM ISO Abbreviation: </i>Int J Tuberc Lung Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41896715 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.5588/ijtld.25.0345 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 167 Titles: – TitleFull: The impact of rifampin drug interactions on tuberculosis preventive treatment completion and safety. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fregonese F – PersonEntity: Name: NameFull: White J – PersonEntity: Name: NameFull: Lim RK – PersonEntity: Name: NameFull: Bedingfield N – PersonEntity: Name: NameFull: Cook VJ – PersonEntity: Name: NameFull: Gafar F – PersonEntity: Name: NameFull: Gibson D – PersonEntity: Name: NameFull: Menzies D – PersonEntity: Name: NameFull: Fisher D IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 03 Text: 2026 Mar 27 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1815-7920 Numbering: – Type: volume Value: 30 – Type: issue Value: 4 Titles: – TitleFull: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease Type: main |
| ResultId | 1 |